Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SCNN1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KIF18B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CABP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MESP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DSG3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LILRA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
C3orf80 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSTM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYS1-DBNDD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
H2AFZ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADNP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THAP9-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RTKN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RMDN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on